Product/Service

BIOIDENT Technologies To Deliver Optoelectronic Lab-On-A-Chip Solutions For Mobile Diagnostics And Analysis

BIOIDENT Technologies Inc., a leading company in the development of printed semiconductor-based photonic lab-on-a-chip solutions for life sciences, today announced it has opened its headquarters in Menlo Park, Calif

Company Opens U.S. Headquarters in Silicon Valley; Appoints Management Team

Menlo Park, CA - BIOIDENT Technologies Inc., a leading company in the development of printed semiconductor-based photonic lab-on-a-chip solutions for life sciences, today announced it has opened its headquarters in Menlo Park, Calif. The company also announced that it has appointed two executives who bring deep expertise in nanotechnology, printed organic semiconductors and biophotonics to BIOIDENT -- Dr. Wasiq Bokhari, CEO and Dr. Max Sonnleitner, CTO.

BIOIDENT is the first and only company to leverage printed optoelectronics and microfluidics to create a new class of photonic lab-on-a-chip systems, which enable real-time, multi-parameter detection and analysis capability for mobile field, diagnostic and point of care applications. BIOIDENT's lab-on-a-chip systems will be used for mobile water and food analysis, chemical and biological agent detection and in-vitro diagnostics. These combined markets currently represent a $2 billion addressable opportunity for BIOIDENT.

Also announced today, BIOIDENT's PhotonicLab Platform(TM) (see related release) will serve as the foundation for this new class of lab-on-a-chip systems with integrated on-chip photonic readout capabilities. The novel platform eliminates the need for external, expensive and bulky readout systems, enabling mobile analytics and diagnostics, immediate test results and a significant cost savings. These breakthrough lab-on-a-chip systems will also analyze multiple test parameters with a single chip in real time, substantially increasing testing efficiencies.

"BIOIDENT technology represents the ideal marriage of printed organic optoelectronic components and microfluidics, which will dramatically transform mobile diagnostic and in-field analysis applications," said Dr. Wasiq Bokhari, CEO for BIOIDENT. "For companies that provide analysis and diagnostic systems, BIOIDENT's unique technology platform can address multiple applications, saving time and money for manufacturers and end customers."

BIOIDENT is a subsidiary of NANOIDENT Technologies AG, the technology leader in the development and manufacture of organic semiconductor-based photonic solutions. NANOIDENT's divisions include NANOIDENT ORGANIC FAB, GmbH and NANOIDENT Biometrics, GmbH. NANOIDENT's extremely fast manufacturing process uses liquid conductive and semiconductive materials to print optoelectronic circuits on almost any surface using inkjet printing, producing products in minutes for both prototype and high volume applications.

"Early on, we recognized the impact that NANOIDENT technology could have for device manufacturers in the life sciences market. By forming a dedicated subsidiary in the U.S., we further the proliferation of NANOIDENT technology globally with the specific resources and expertise required for life sciences," said Klaus G. Schroeter, CEO, NANOIDENT Technologies AG. "BIOIDENT's new PhotonicLab Platform further specializes available NANOIDENT technology, enabling completely new mass markets for mobile analytics and mobile diagnostics."

SOURCE: BIOIDENT Technologies Inc.